Palo Alto, CA, United States of America

Joel Naor

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Eye Disorder Treatment by Joel Naor

Introduction

Joel Naor is an accomplished inventor based in Palo Alto, CA. He has made significant contributions to the field of ophthalmology through his innovative approaches to treating eye disorders. His work focuses on the development of methods that enhance the effectiveness of existing therapies.

Latest Patents

Joel Naor holds a patent for "Methods of treating an eye disorder." This patent outlines methods for treating eye disorders by administering an anti-VEGF antibody and/or conjugate to a subject suffering from an eye condition. The anti-VEGF antibody described in the patent may include a polymeric moiety that extends its half-life and effectiveness when administered. This innovative approach allows for less frequent administration compared to standard anti-VEGF therapies, providing a more convenient treatment option for patients.

Career Highlights

Naor is currently associated with Kodiak Sciences Inc., where he continues to work on groundbreaking treatments for eye disorders. His dedication to research and development has positioned him as a key figure in the field.

Collaborations

Throughout his career, Joel has collaborated with notable colleagues, including Jason Ehrlich and Pablo Velazquez-Martin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Joel Naor's contributions to the treatment of eye disorders exemplify the impact of innovative thinking in medicine. His patent for methods of treating eye disorders showcases his commitment to improving patient care through advanced therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…